Tibet AIM Pharm. Inc.

002826

CNE100002C39

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
9.74 ^CNY	+7.03%		+5.98%	-17.94%

Apr. 25	Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.	CI

Tibet AIM Pharm. Inc. cancelled the transaction announced on April 6, 2021

August 12, 2021

On August 13, 2021, Tibet AIM Pharm. Inc. cancelled the transaction. The cancellation is approved by board of directors in its 20th session of the company’s 2nd directorate and the 19th session of the company’s 2nd supervisory.

Latest news about Tibet AIM Pharm. Inc.

Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.	Apr. 01	CI
Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.	Jan. 02	CI
Tibet AIM Pharm. Inc. announces an Equity Buyback for CNY 100 million worth of its shares.	23-10-29	CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Tibet AIM Pharm. Inc. authorizes a Buyback Plan.	23-10-25	CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-16	CI
Tibet Aim Pharm Chairman Resigns; Successor Named	23-02-12	MT
Tibet Aim Pharm Unit to Buy 21% Stake in US Medtech Firm Pier 88 Health for $6 Million	23-02-12	MT
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-08	CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-24	CI
Tibet AIM Pharm. Inc. Approves the Election of Non-Independent Directors, Independent Directors and Non-Employee Supervisors	21-09-14	CI
Tibet Aim Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Tibet AIM Pharm. Inc. agreed to acquire 51% stake in Inner Mongolia Bositai Enterprise Management Service Co., Ltd. for CNY 30.6 million.	21-08-13	CI
Tibet AIM Pharm. Inc. cancelled the transaction announced on April 6, 2021	21-08-12	CI
Tibet Aim Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Tibet AIM Pharm. Inc. announced that it expects to receive CNY 349.999994 million in funding	21-04-05	CI
Tibet Aim Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-28	CI
Tibet Aim Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-25	CI
Tibet Aim Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-27	CI

Chart Tibet AIM Pharm. Inc.

Duration

Period

More charts

Company Profile

TIBET AIM PHARM INC is a China-based company principally engaged in the research, design, manufacture and distribution of chemical drugs and Chinese patent medicine. The Companyâs products include self-manufacturing medicine and third-party medicine. Self-manufacturing medicine includes miglitol tablets, hongjinxiaojie tablet, aceclofenac enteric-coated tablets, montmorillonite powder, as well as domperidone tablets, among others. Its third-party medicine includes gualoupi injection, nalmefene hydrochloride injection, oral liquid for children, cefotaxime sodium for injection, as well as carbetocin injection. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-05-17 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TIBET AIM PHARM. INC.	-17.94%	235M
ELI LILLY AND COMPANY	+29.57%	682B
NOVO NORDISK A/S	+30.35%	586B
JOHNSON & JOHNSON	-3.73%	364B
MERCK & CO., INC.	+17.67%	327B
ABBVIE INC.	+3.26%	285B
ASTRAZENECA PLC	+15.53%	240B
NOVARTIS AG	+10.16%	209B
ROCHE HOLDING AG	-8.14%	203B
AMGEN INC.	+7.42%	165B

Other Pharmaceuticals